company background image
FME logo

Fresenius Medical Care XTRA:FME Rapport sur les actions

Dernier prix

€34.93

Capitalisation boursière

€10.2b

7D

3.6%

1Y

-21.9%

Mise à jour

27 Aug, 2024

Données

Finances de l'entreprise +

Fresenius Medical Care AG

XTRA:FME Rapport sur les actions

Capitalisation boursière : €10.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

FME Aperçu des actions

Fresenius Medical Care AG fournit des services de dialyse et des services connexes aux personnes souffrant de maladies rénales en Allemagne, en Amérique du Nord et dans le monde entier.

FME analyse fondamentale
Score flocon de neige
Évaluation4/6
Croissance future3/6
Performances passées1/6
Santé financière4/6
Dividendes5/6

Fresenius Medical Care AG Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Fresenius Medical Care
Historique des cours de bourse
Prix actuel de l'action€34.93
Plus haut sur 52 semaines€45.29
Plus bas sur 52 semaines€30.16
Bêta0.86
1Variation sur 1 mois-6.05%
Variation sur 3 mois-8.92%
Variation sur 1 an-21.91%
3Variation sur 3 ans-46.29%
Variation sur 5 ans-42.87%
Évolution depuis l'introduction en bourse113.20%

Nouvelles et mises à jour récentes

At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Aug 20
At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 02
Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

Jun 17
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

Recent updates

At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Aug 20
At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 02
Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

Jun 17
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

May 30
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

May 10
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Feb 03
Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Jan 19
Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Jan 04
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Dec 17
Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Rendement pour les actionnaires

FMEDE HealthcareDE Marché
7D3.6%1.7%0.9%
1Y-21.9%-1.2%4.9%

Rendement vs Industrie: FME a sous-performé le secteur German Healthcare qui a rapporté -2 % au cours de l'année écoulée.

Rendement vs marché: FME a sous-performé le marché German qui a rapporté 4.7 % au cours de l'année écoulée.

Volatilité des prix

Is FME's price volatile compared to industry and market?
FME volatility
FME Average Weekly Movement3.5%
Healthcare Industry Average Movement3.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.1%
10% least volatile stocks in DE Market2.5%

Cours de l'action stable: FME n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de FME ( 4% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
1996113,639Helen Gizawww.freseniusmedicalcare.com

Fresenius Medical Care AG fournit des services de dialyse et des services connexes aux personnes souffrant de maladies rénales en Allemagne, en Amérique du Nord et dans le monde entier. La société propose des traitements par dialyse et des services de laboratoire et de diagnostic connexes par l'intermédiaire d'un réseau de cliniques de dialyse ambulatoires ; du matériel, de la formation et des services d'aide aux patients comprenant la surveillance clinique, l'assistance au suivi et l'organisation de la livraison des fournitures au domicile du patient ; et des services de dialyse sous contrat avec des hôpitaux aux États-Unis pour les patients hospitalisés en insuffisance rénale terminale et pour les patients souffrant d'une insuffisance rénale aiguë. Elle développe, fabrique et distribue également divers produits de soins de santé, notamment des dialyseurs en polysulfone, des appareils d'hémodialyse, des cycleurs de dialyse péritonéale, des solutions de dialyse péritonéale, des concentrés, solutions et granulés d'hémodialyse, des lignes sanguines, des produits pharmaceutiques rénaux, des systèmes de traitement de l'eau et des produits d'aphérèse et de cardiopulmonaire aiguës.

Fresenius Medical Care AG Résumé des fondamentaux

Comment les bénéfices et les revenus de Fresenius Medical Care se comparent-ils à sa capitalisation boursière ?
FME statistiques fondamentales
Capitalisation boursière€10.25b
Bénéfices(TTM)€530.26m
Recettes(TTM)€19.42b

19.3x

Ratio P/E

0.5x

Ratio P/S

Le site FME est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
FME compte de résultat (TTM)
Recettes€19.42b
Coût des recettes€14.50b
Marge brute€4.92b
Autres dépenses€4.39b
Les revenus€530.26m

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

Nov 05, 2024

Résultat par action (EPS)1.81
Marge brute25.33%
Marge bénéficiaire nette2.73%
Ratio dettes/capitaux propres50.6%

Quelles ont été les performances à long terme de FME?

Voir les performances historiques et les comparaisons

Dividendes

3.4%

Rendement actuel des dividendes

66%

Ratio de distribution